Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1995
10/26/1995WO1995028158A1 Intranasal antimigraine composition
10/26/1995WO1995028157A1 Use of alpha-1c specific compounds to treat benign prostatic hyperplasia
10/26/1995WO1995028156A1 Treating estrogen-dependent diseases with (-)-fadrozole
10/26/1995WO1995028153A1 Benzamide-containing pharmaceutical compositions
10/26/1995WO1995028152A1 Methods and compositions for treating depression and other disorders using optically pure s(+) fluoxetine
10/26/1995WO1995028151A1 Use of maillard reaction inhibitors for the treatment of amyloidosis-based disease
10/26/1995WO1995028148A1 Pharmaceutical formulation
10/26/1995WO1995028145A1 Iontophoretic delivery of bisphosphonates to the alveolar bone
10/26/1995WO1995028084A1 Ascorbic acid composition providing enhanced human immune system activity
10/26/1995WO1995022537A3 4-amino derivatives of 5-substituted mycophenolic acid
10/26/1995DE4412612A1 Medical and veterinary use of synthetic humate prods.
10/26/1995DE4412464A1 New medicaments contg. steroid and antioxidant
10/26/1995DE4410997A1 Pharmazeutische Zubereitungen und Arzneistoffe zur Prävention und Behandlung endothelialer Dysfunktionen Pharmaceutical drugs for the prevention and treatment of endothelial dysfunction
10/26/1995CA2189028A1 Hek5, hek7, hek8, hek11, new eph-like receptor protein tyrosine kinases
10/26/1995CA2187794A1 Benzamide-containing pharmaceutical compositions
10/26/1995CA2187791A1 Inhibitors of influenza virus neuraminidase and methods of making and using the same
10/26/1995CA2187773A1 Use of alpha-1c specific compounds to treat benign prostatic hyperplasia
10/26/1995CA2187768A1 Aqueous solvent encapsulation method, apparatus and microcapsules
10/26/1995CA2187767A1 Alpha1c adrenergic receptor antagonists
10/26/1995CA2187528A1 Chelant compounds
10/26/1995CA2187526A1 Methods of use of uncoated gel particles
10/26/1995CA2187086A1 A pharmaceutical composition for therapeutically treating tardive dyskinesia and uses therof
10/26/1995CA2186900A1 Cck or gastrin modulating 5-heterocyclic-1,5-benzodiazepines
10/26/1995CA2186872A1 Cck or gastrin modulating 1,5 benzodiazepines derivatives
10/26/1995CA2186738A1 Enteral formulations for the treatment of inflammation and infection containing a saponin, possibly in combination with other compounds
10/26/1995CA2186639A1 Cell-cycle regulatory proteins, and uses related thereto
10/26/1995CA2186252A1 Substituted pyridine leukotriene b4 antagonists
10/26/1995CA2163773A1 Abeo-ergoline derivatives as 5ht1a ligands
10/25/1995EP0678516A1 Preparation of 2-bromo-5-(2-bromo-2-nitrovinyl)-furan and its use as microcide
10/25/1995EP0678511A2 Thiazolidine and oxazolidine derivatives, their preparation and their medical use
10/25/1995EP0678508A1 Indoles as inhibitors of HIV reverse transcriptase
10/25/1995EP0678507A1 Method for preparing homochiral maleimide intermediates, via silylation techniques, used in the enantioselective preparation of anti-thrombotic and anti-vasospastic compounds
10/25/1995EP0678503A1 Delta-amino-gamma-hydroxy-omega-aryl alkanoic acid amides with enzyme especially renin inhibiting activities
10/25/1995EP0678495A2 Process for the purification of perfluoroalkylbromides or perfluoroalkylene dibromides
10/25/1995EP0678299A2 Pharmaceutical compositions containing one or more of gamma-linolenic acid dihomogamma linolenic and an arachidonic acid
10/25/1995EP0678298A2 Use of 4-(2-formyl-3-hydroxyphenoxymethyl)benzoic acid as immopotentiatory agent
10/25/1995EP0678297A1 Iontophoretic transdermal delivery of deoxyspergualin compounds
10/25/1995EP0678296A1 Vascularization inhibitor and novel compound
10/25/1995EP0678293A2 Composition containing pyridoxine ester, process for the preparation and use thereof
10/25/1995EP0678121A1 Methods and reagents for inhibiting furin endoprotease
10/25/1995EP0678101A1 Growth differentiation factor-9
10/25/1995EP0678098A1 Pyrrolidine and thiazolidine derivatives, their preparation and drugs containing same
10/25/1995EP0678097A1 Novel colon- or ileum-specific steroid derivatives
10/25/1995EP0678095A1 Crystalline penicillin derivative, and its production and use
10/25/1995EP0678090A1 Piperazine derivatives
10/25/1995EP0678089A1 N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders.
10/25/1995EP0678088A1 N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders.
10/25/1995EP0678087A1 Compounds having selective activity for retinoid x receptors, and means for modulation of processes mediated by retinoid x receptors
10/25/1995EP0678086A1 Compounds having selectivity for retinoid x receptors
10/25/1995EP0678030A1 Use of sulphated polysaccharides for preventing sexually transmitted diseases
10/25/1995EP0678027A1 Anti-atherosclerotic agents
10/25/1995EP0678026A1 Application of carbamazepine and oxcarbazepine in the treatment of parkinson's disease and parkinsonian syndromes.
10/25/1995EP0678025A1 Transdermal treatment of cancer with water-insoluble s-camptothecin of the closed lactone ring form
10/25/1995EP0678024A1 Use of idazoxan and its derivatives in the treatment of alzheimer-type senility
10/25/1995EP0678023A1 Application of riluzole in the treatment of parkinson's disease and parkinsonian syndromes.
10/25/1995EP0678022A1 Application of riluzole as a radiorestorer.
10/25/1995EP0678021A1 Methods for the improvement of cognition with functional antagonists of the glycine nmda receptor complex
10/25/1995EP0678020A1 Compositions comprising cholesterol lowering agents and antioxidants
10/25/1995EP0678019A1 Enhanced solubility pharmaceutical solutions
10/25/1995EP0678016A1 Topical compositions for the eye comprising a beta-cyclodextrin derivative and a carbonic anhydrase inhibitor
10/25/1995EP0677990A1 Compositions and uses thereof
10/25/1995EP0598765B1 2-aminonaphthyridine derivative, its preparation and use
10/25/1995EP0483273B1 Dispenser comprising ionophore
10/25/1995EP0406413B1 Scanning type tunnel microscope
10/25/1995CN1110865A Amino acid derivative
10/25/1995CN1110717A Extracting polyse protein from "Xianggu" mushroom with enzyme method and technology for preparation of polyose protein capsule
10/25/1995CN1110685A Nitrogen-containing spirocycles
10/25/1995CN1110556A Pharmaceutical containg 3-benzoyl-3,7-diazabicydo |3.3.1¨nonan compound
10/25/1995CN1110555A Medical silicon cream and its series products
10/25/1995CN1030141C Process for proaartion of 4'-demethylepipodophyllotixin glucoside 4'-phosphates
10/25/1995CN1030133C 1,6-fructose diphosphate sodium salt oral liquid
10/24/1995USRE35072 4-substituted pyrazolo[3,4-d]pyrimidine derivatives
10/24/1995US5461176 Reacting alanine methyl ester with oxalyl chloride, treating with ammonia in methanol, reducing amides with diborane in tetrahydrofuran, neutralizing with sodium ethoxide to yield free amine
10/24/1995US5461175 Method for separating enantiomers of aryloxipropanolamine derivatives, and chiral solid-phase chromatography material for use in the method
10/24/1995US5461168 Processes for the production of 13-ether derivatives of milbemycins, and intermediates therefor
10/24/1995US5461156 Stereocontrolled synthesis of cis-bicyclic compounds
10/24/1995US5461154 HIV protease inhibitors
10/24/1995US5461152 Carbocyclic nucleosides containing bicycle rings, oligonucleotides therefrom, process for their preparation, their use and intermediates
10/24/1995US5461146 Enzyme inhibitor protecting nerve cells from degeneration
10/24/1995US5461080 Using vapor phase antioxidant
10/24/1995US5461078 Anti-cancer compounds
10/24/1995US5461075 Use of vanilloids for the prevention of lesions due to herpes simplex infections
10/24/1995US5461073 Septicemia suppressing substitution fluid preparation
10/24/1995US5461072 Use of aryl hydroxyurea compounds for the treatment of atherosclerosis
10/24/1995US5461070 Anti-flammatory method using indole alkaloids
10/24/1995US5461068 Imidazole derivative tincture and method of manufacture
10/24/1995US5461067 For HIV infections
10/24/1995US5461066 Antiarrthythmic agent
10/24/1995US5461065 Methods for inhibiting endometriosis
10/24/1995US5461064 Methods of inhibiting atrophy of the skin and vagina
10/24/1995US5461062 Condensed imidazopyridine derivatives
10/24/1995US5461061 Antidepressants
10/24/1995US5461059 Derivatives of terbutylphenyl-1-amino-4-hydroxybutane their preparation processes and the pharmaceutical compositions containing them
10/24/1995US5461058 Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof
10/24/1995US5461056 Psoriasis, atopic dermatitis
10/24/1995US5461054 Anthracene-spiro-pyrrolindines
10/24/1995US5461052 Prevention of myopia by tricyclic compounds
10/24/1995US5461050 Antiallergens
10/24/1995US5461047 2-,3-,4-,5-,6-,7-,8-,9- and/or 10-substituted dibenzoxazepine and dibenzthiazepine compounds, pharmaceutical compositions and methods of use
10/24/1995US5461045 Treating thrombosis, arteriosclerosis, ischemic heart diseases, gastric ulcer and hypertension
1 ... 6973 6974 6975 6976 6977 6978 6979 6980 6981 6982 6983 6984 6985 6986 6987 6988 6989 6990 6991 6992 6993 ... 7860